pharma

Oregon Lawmakers Mull Changes To Strengthen Drug Transparency Program 

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

Oregon lawmakers are considering changes to the state’s drug transparency law that would prevent pharmaceutical manufacturers from exploiting a potential loophole to avoid reporting price hikes and give state regulators more authority to expect timely information from drug companies.

By: 
Ben Botkin

First Round of Oregon v. Pharma. State Publishes Data And Stories. Next Up: Trade Secrets

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

An Oregon program that aims to peel back the opaque layers of prescription drug pricing wrapped up its first year this week with a report to the Legislature that underlines

By: 
Lynne Terry

Lower Drug Prices Are ‘Very Feasible’ In Oregon, Advocate says

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

By: 
Alex Visser

Lawmakers Aim To Fix Potentially Serious Language Problem With Medications

This article is for premium subscribers!

To read further, please sign up for a premium subscription. You can also read more about standard and premium subscriptions here. Your subscription dollars are tax deductible and support the in-depth stories you appreciate from The Lund Report. If you believe you already are a premium subscriber, you are already logged in, and you are getting this message, please contact [email protected] Thanks!

If you are a premium subscriber that is not logged in, please login now.

For people who don’t read much English, following prescription labels can be a guessing game. Those who guess wrong can end up hurt by the medication that was supposed to help them. Even worse, they can end up hospitalized.

By: 
Alex Visser

Legislator, Opponent Clash Over Prescription Drug Bill

A rare scene of drama erupted in a House health care committee hearing on Tuesday as the chair and a lobbyist for the pharmaceutical industry clashed over a fairly straightforward bill that would require greater transparency on the part of drug manufacturers.

By: 
Alex Visser

Pages

Subscribe to pharma